Science & Research

High Androgen Index and Hair Loss Tracking: DHT Sensitivity Profiling

February 23, 20266 min min read1,200 words

High Androgen Index and Hair Loss Tracking: DHT Sensitivity Profiling

A free androgen index above 40 is associated with 2.3x faster androgenetic alopecia progression regardless of total testosterone level. Understanding your personal androgen profile, and tracking how it correlates with density changes, gives you a critical advantage in treatment planning.

What Is the Free Androgen Index?

The free androgen index (FAI) is a calculated ratio that estimates the amount of biologically active testosterone in your blood. It is calculated as:

FAI = (Total Testosterone / SHBG) x 100

Where SHBG is sex hormone-binding globulin, a protein that binds to testosterone and makes it inactive.

FAI RangeClassificationAGA Risk Implication
Below 30Normal/lowStandard progression risk
30 to 50Moderate-highAbove-average progression rate
50 to 70HighSignificantly accelerated risk
Above 70Very highRapid progression likely

A high FAI means more free testosterone is available for conversion to DHT by the enzyme 5-alpha reductase. More available DHT reaching sensitive follicles means faster miniaturization.

Why Total Testosterone Is Misleading

Many men get a testosterone blood test and assume their hair loss risk correlates directly with the result. This is incorrect for two reasons:

  1. SHBG modulates bioavailability. A man with high total testosterone but high SHBG may have less biologically active testosterone than a man with moderate total testosterone and low SHBG.

  2. Follicular receptor sensitivity varies genetically. Two men with identical free testosterone levels can lose hair at completely different rates because their androgen receptor (AR) gene variants differ.

The combination of FAI and density tracking addresses both problems. FAI tells you how much active androgen is reaching your follicles. Density tracking tells you how your follicles are responding.

The Blood Panel You Need

To build a complete androgen profile alongside your density data, request the following blood tests:

TestPurposeTypical Range (Adult Male)
Total testosteroneBaseline hormone level300 to 1,000 ng/dL
Free testosteroneUnbound, active testosterone5 to 21 ng/dL
SHBGBinding protein level10 to 57 nmol/L
DHT (dihydrotestosterone)Active androgen at follicle level30 to 85 ng/dL
DHEA-SAdrenal androgen contribution100 to 500 mcg/dL

Request this panel from your primary care physician or endocrinologist. Test in the morning (before 10 AM) when testosterone levels are at their peak for the most consistent results.

How to Correlate Blood Work with Density Data

Step 1: Get Your Baseline Blood Panel

Have your blood drawn and record all values with the date. This is your hormonal baseline.

Step 2: Start Density Tracking

Begin scanning with myhairline.ai every 2 weeks across all zones (frontal, mid-scalp, vertex, donor).

Step 3: Repeat Blood Work at 3 to 6 Month Intervals

Hormonal levels fluctuate with age, stress, sleep, exercise, and diet. Repeat the panel every 3 to 6 months to track trends.

Step 4: Overlay the Data

Create a simple comparison:

DateFAIFrontal DensityVertex DensityTreatment
Month 055BaselineBaselineNone
Month 352-3%-5%None
Month 648-2% (on Fin)-1% (on Fin)Finasteride started Month 3
Month 945+1%+2%Finasteride
Month 1244+2%+3%Finasteride

This overlay reveals whether your treatment is keeping pace with your androgen activity.

What High FAI Means for Treatment Selection

Your FAI level directly impacts which treatments are likely to be most effective.

Men with FAI above 50 typically benefit from:

  • Finasteride 1mg daily: Reduces DHT by approximately 60 to 70%. This is the first-line defense for high-FAI men. Efficacy: 80 to 90% halt further loss, 65% experience regrowth. Side effects occur in 2 to 4% of users and are reversible on discontinuation.

  • Dutasteride 0.5mg daily (off-label): Reduces DHT by approximately 90%. May be necessary for men whose FAI is so high that finasteride's 60 to 70% reduction is insufficient.

  • Topical anti-androgens: Topical finasteride or spironolactone can supplement oral treatment for high-FAI patients.

  • PRP therapy: $500 to $2,000 per session, 30 to 40% density increase in studies. Complements anti-androgen therapy by stimulating growth factors independently.

Moderate FAI (30 to 50): Standard Approach

  • Finasteride monotherapy is often sufficient
  • Minoxidil (40 to 60% experience moderate regrowth) as an adjunct
  • Monitor density every 2 weeks to confirm response within 6 months

Low FAI (Below 30): Investigate Other Causes

If your FAI is low but you are losing hair, other factors may be driving your loss:

  • Thyroid dysfunction
  • Iron deficiency
  • Chronic telogen effluvium from stress or illness
  • Autoimmune alopecia (areata)

Density tracking helps differentiate these patterns from androgenetic alopecia by revealing zone-specific loss patterns.

The DHT Sensitivity Spectrum

Even within a given FAI range, individual follicle sensitivity varies. This is determined by the androgen receptor (AR) gene on the X chromosome, which you inherit from your mother's side.

Tracking allows you to place yourself on the sensitivity spectrum empirically:

High sensitivity indicators (from tracking data):

  • Rapid density decline (more than 5% per quarter) despite moderate FAI
  • Loss concentrated heavily at the vertex (where androgen receptors are most dense)
  • Poor response to finasteride alone (density continues to decline after 12 months on treatment)

Lower sensitivity indicators:

  • Slow density decline (less than 2% per quarter) even with high FAI
  • Loss primarily at the temples (less androgen receptor-dense area)
  • Strong stabilization on finasteride within 6 months

Tracking Finasteride Response with Your FAI Data

When you start finasteride, your tracking data answers the critical question: is the DHT reduction sufficient for your personal sensitivity level?

Here is what to expect:

TimelineExpected Response (Responsive)Red Flag (Non-Responsive)
Months 1 to 3Possible shedding (normal)No change
Months 3 to 6Density stabilizationContinued decline over 3%
Months 6 to 12Mild improvement or stableDecline exceeding 5%
Month 12+Stable or improvedOngoing loss despite treatment

If your density continues to decline after 12 months on finasteride, your FAI and tracking data together suggest that you may need a more aggressive anti-androgen approach, such as dutasteride, or combination therapy with minoxidil.

Take Action

Understanding your androgen profile turns hair loss treatment from guesswork into precision medicine. A blood panel costs $50 to $150 out of pocket, and the density data to correlate it with is available through your phone.

Start your free density analysis at myhairline.ai/analyze and pair it with your next blood panel to build your personal DHT sensitivity profile.


Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Blood test interpretation should be done by a qualified physician. Finasteride and dutasteride are prescription medications with potential side effects. Always consult a board-certified dermatologist or endocrinologist before starting or modifying any hormonal treatment.

Frequently Asked Questions

Total DHT level measures the amount of dihydrotestosterone circulating in your blood. Androgen sensitivity refers to how strongly your hair follicles respond to that DHT. Two men with identical DHT levels can experience completely different rates of hair loss because their follicular androgen receptor density and sensitivity differ. The free androgen index (FAI) is a better predictor of progression than total DHT alone.

Ready to Assess Your Hair Loss?

Get an AI-powered Norwood classification and personalized graft estimate in 30 seconds. No downloads, no account required.

Start Free Analysis